This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoffman, J. M. Articles by Krohn, K. A. Search for Related Content PubMed PubMed Citation Articles by Hoffman, J. M. Articles by Krohn, K. A.

Stroke, Vol 18, 168-176, Copyright © 1987 by American Heart Association

ARTICLES

Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia

JM Hoffman, JS Rasey, AM Spence, DW Shaw and KA Krohn

Radiolabelled misonidazole, a radiosensitizing drug that binds to viable hypoxic tumor cells, may be useful in identifying hypoxic cells in cerebrovascular disease. Its potential was investigated in the gerbil stroke model. Biodistribution of [3H]misonidazole was measured in normal gerbils and animals that had been subjected to right common carotid artery ligation to produce cerebral ischemia. The uptake of [3H]misonidazole in the right cerebral hemisphere and right/left hemispheral uptake ratios correlated positively with the severity of the stroke when measured 6-9 hours after carotid ligation. Histologic studies in symptomatic ligated animals showed ipsilateral widespread but patchy acute ischemic changes as well as areas that showed no morphological changes. Microscopic autoradiography in these animals showed diffuse heavy labelling only in the ipsilateral hemisphere. This was over areas that had histological damage as well as in adjacent areas that appeared intact. Studies comparing blood flow measured with [14C]iodoantipyrine and [3H]misonidazole retention in gerbils with carotid artery ligations indicated that flow is not a major determinant of retention of this hypoxia tracer. We conclude that a misonidazole congener labelled with a gamma- or positron-emitting isotope may be useful in nuclear imaging of the degree and regional distribution of hypoxic tissue in cerebrovascular disease.

This article has been cited by other articles:

				K. A. Krohn, J. M. Link, and R. P. Mason Molecular Imaging of Hypoxia J. Nucl. Med., June 1, 2008; 49(Suppl_2): 129S - 148S. [Abstract] [Full Text] [PDF]

				M. Takasawa, R. R. Moustafa, and J.-C. Baron Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke Stroke, May 1, 2008; 39(5): 1629 - 1637. [Abstract] [Full Text] [PDF]

				R. Markus, D. C. Reutens, S. Kazui, S. Read, P. Wright, D. C. Pearce, H. J. Tochon-Danguy, J. I. Sachinidis, and G. A. Donnan Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival Brain, June 1, 2004; 127(6): 1427 - 1436. [Abstract] [Full Text] [PDF]

				K. Saita, M. Chen, N. J. Spratt, M. J. Porritt, G. T. Liberatore, S. J. Read, C. R. Levi, G. A. Donnan, U. Ackermann, H. J. Tochon-Danguy, et al. Imaging the Ischemic Penumbra with 18F-Fluoromisonidazole in a Rat Model of Ischemic Stroke Stroke, April 1, 2004; 35(4): 975 - 980. [Abstract] [Full Text] [PDF]

				H.-C. Song, H.-S. Bom, K. H. Cho, B. C. Kim, J.-J. Seo, C.-G. Kim, D. J. Yang, and E. E. Kim Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m--Labeled Metronidazole Stroke, April 1, 2003; 34(4): 982 - 986. [Abstract] [Full Text] [PDF]

				T. Hirano, S. J. Read, D. F. Abbott, J. I. Sachinidis, H. J. Tochon-Danguy, G. F. Egan, C. F. Bladin, A. M. Scott, W. J. McKay, and G. A. Donnan No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage Neurology, December 1, 1999; 53(9): 2179 - 2179. [Abstract] [Full Text]